<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37316880</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6963</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>14</Day></PubDate></JournalIssue><Title>BMC health services research</Title><ISOAbbreviation>BMC Health Serv Res</ISOAbbreviation></Journal><ArticleTitle>Long COVID: Costs for the German economy and health care and pension system.</ArticleTitle><Pagination><StartPage>641</StartPage><MedlinePgn>641</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">641</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12913-023-09601-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with acute COVID-19 can develop persistent symptoms (long/post COVID-19 syndrome). This study aimed to project the economic, health care, and pension costs due to long/post-COVID-19 syndrome with new onset in Germany in 2021.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using secondary data, economic costs were calculated based on wage rates and the loss of gross value-added. Pension payments were determined based on the incidence, duration, and amount of disability pensions. Health care expenditure was calculated based on rehabilitation expenses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The analysis estimated a production loss of 3.4 billion euros. The gross value-added loss&#xa0;was calculated to be 5.7 billion euros. The estimated financial burden on the health care and pension systems due to&#xa0;SARS-CoV-2 infection was approximately 1.7 billion euros. Approximately 0.4 percent of employees are projected to be wholly or partially withdrawn from the labor market in the medium term due to long/post-COVID with new onset in 2021.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Costs of long/post-COVID-19 syndrome with new onset in 2021 are not negligible for the German economy and health care and pension systems but may still be manageable.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gandjour</LastName><ForeName>Afschin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Frankfurt School of Finance &amp; Management, Adickesallee 32-34, 60322, Frankfurt, Germany. a.gandjour@fs.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Health Serv Res</MedlineTA><NlmUniqueID>101088677</NlmUniqueID><ISSNLinking>1472-6963</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005102" MajorTopicYN="N">Health Expenditures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010415" MajorTopicYN="N">Pensions</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The author declares that he has no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37316880</ArticleId><ArticleId IdType="pmc">PMC10266873</ArticleId><ArticleId IdType="doi">10.1186/s12913-023-09601-6</ArticleId><ArticleId IdType="pii">10.1186/s12913-023-09601-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022 doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, Steves CJ. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmer Institut f&#xfc;r Gesundheitssystemforschung (2021), bifg-Analyse zu Arbeitsunf&#xe4;higkeiten wegen COVID-19 und Post-COVID-Symptomen. Juni 2021. http://docs.dpaq.de/17738-20210616_bifg_epaper_post-covid_bf.pdf.</Citation></Reference><Reference><Citation>Barmer. Die Barmer. January 1, 2023. https://www.barmer.de/ueberuns/barmer/unternehmen-1056674#:~:text=Ihre%208%2C7%20Millionen%20Versicherten,durch%20F%C3%B6rderung%20der%20individuellen%20Gesundheitskompetenz.</Citation></Reference><Reference><Citation>Bundesagentur f&#xfc;r Arbeit (2022), Monatsbericht zum Arbeits- und Ausbildungsmarkt. M&#xe4;rz 2022. https://statistik.arbeitsagentur.de/Statistikdaten/Detail/202203/arbeitsmarktberichte/monatsbericht-monatsbericht/monatsbericht-d-0-202203-pdf.pdf?__blob=publicationFile&amp;v=1.</Citation></Reference><Reference><Citation>Bundesanstalt f&#xfc;r Arbeitsschutz und Arbeitsmedizin. Volkswirtschaftliche Kosten durch Arbeitsunf&#xe4;higkeit. Januar 2022. https://www.baua.de/DE/Themen/Arbeitswelt-und-Arbeitsschutz-im-Wandel/Arbeitsweltberichterstattung/Kosten-der-AU/Kosten-der-Arbeitsunfaehigkeit_node.html.</Citation></Reference><Reference><Citation>Bundesarbeitsgemeinschaft f&#xfc;r Rehabilitation e.V. (BAR) (2021), Bestandsaufnahme zu Long COVID in der medizinischen Rehabilitation: Ergebnisse einer quantitativen Befragung, 2021. Online-Publikation. Frankfurt/Main, Oktober 2021. https://www.bar-frank-furt.de/fileadmin/dateiliste/_publikationen/reha_entwicklungen/pdfs/RehaEntwicklungen_LongCovid_220214_bf.pdf.</Citation></Reference><Reference><Citation>Bundesarbeitsgemeinschaft f&#xfc;r Rehabilitation e.V. (BAR) (2022), Ausgestaltung der medizinischen Reha f&#xfc;r Menschen mit Long COVID. https://www.bar-frankfurt.de/themen/weiterentwicklung-und-forschung/long-covid-in-der-reha-erhebung/ausgestaltung-der-medizinischen-rehabilitation-fuer-menschen-mit-long-covid.html.</Citation></Reference><Reference><Citation>Deutscher Bundestag. Antwort der Bundesregierung auf die Kleine Anfrage der Abgeordneten Kordula Schulz-Asche, Maria Klein-Schmeink, Dr. Kirsten Kappert-Gonther, weiterer Abgeordneter und der Fraktion B&#xdc;NDNIS 90/DIE GR&#xdc;NEN. Drucksache 19/32135. 20.09.2021. https://dserver.bundestag.de/btd/19/325/1932509.pdf.</Citation></Reference><Reference><Citation>Calabrese LH, Calabrese CM. Long COVID: defining the role of rheumatology in care and research. Lancet Rheumatol. 2022;4(12):e812&#x2013;e814. doi: 10.1016/S2665-9913(22)00266-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(22)00266-1</ArticleId><ArticleId IdType="pmc">PMC9529216</ArticleId><ArticleId IdType="pubmed">36211989</ArticleId></ArticleIdList></Reference><Reference><Citation>Close S, Marshall-Gradisnik S, Byrnes J, Smith P, Nghiem S, Staines D. The Economic Impacts of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in an Australian Cohort. Front Public Health. 2020;8:420. doi: 10.3389/fpubh.2020.00420.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00420</ArticleId><ArticleId IdType="pmc">PMC7472917</ArticleId><ArticleId IdType="pubmed">32974259</ArticleId></ArticleIdList></Reference><Reference><Citation>Crampton E., Burgess M. &amp; Taylor B. (2011). The Cost of Cost Studies. Christchurch, NZ: Department of Economics &amp; Finance, University of Canterbury, Working Paper No. 29/2011. Retrieved from http://www.econ.canterbury.ac.nz/RePEc/cbt/econwp/1129.pdf.</Citation></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Deutsche Gesellschaft f&#xfc;r Pneumologie und Beatmungsmedizin e.V. (DGP) (2021), S1-Leitlinie Post-COVID/Long-COVID. Stand 12.07.2021. https://www.awmf.org/uploads/tx_szleitlinien/020-027l_S1_Post_COVID_Long_COVID_2021-07.pdf.</Citation></Reference><Reference><Citation>Deutsche Gesetzliche Unfallversicherung (2020), DGUV-Statistiken f&#xfc;r die Praxis 2020. https://publikationen.dguv.de/widgets/pdf/download/article/4290.</Citation></Reference><Reference><Citation>Deutsche Gesetzliche Unfallversicherung (2022), Berufskrankheiten und Arbeitsunf&#xe4;lle im Zusammenhang mit COVID-19. Stand: 13.05.2022. https://www.dguv.de/medien/inhalt/mediencenter/hintergrund/covid/dguv_zahlen_covid.pdf.</Citation></Reference><Reference><Citation>Deutsche Gesetzliche Unfallversicherung (2022), Berufskrankheitengeschehen. https://www.dguv.de/de/zahlen-fakten/bk-geschehen/index.jsp.</Citation></Reference><Reference><Citation>Deutsche Rentenversicherung (2021), Erwerbsminderungsrenten im Zeitablauf 2021. Stand 27.07.2021. https://www.deutsche-rentenversicherung.de/SharedDocs/Downloads/DE/Statistiken-und-Berichte/statistikpublikationen/erwerbsminderungsrenten_zeitablauf_2021.html.</Citation></Reference><Reference><Citation>Deutsche Rentenversicherung (2022), Herzprobleme, Luftnot, Angst: Wie Long COVID bei Patienten zuschl&#xe4;gt. 12.01.2022. https://www.deutsche-rentenversicherung.de/Bund/DE/Aktuelles/Meldungen/220112_dpa_rossbach_post-covid.html#:~:text=Long%20COVID%20hilft.-,%E2%80%9C,nicht%20um%20eine%20beunruhigende%20Gr%C3%B6%C3%9Fenordnung.</Citation></Reference><Reference><Citation>ExpertInnenrates der Bundesregierung zu COVID-19 (2022), 9. Stellungnahme &#x2013; Long Covid. 15.05.2022. https://www.bundesregierung.de/resource/blob/975196/2040048/feffdcc21a9892def37df142e4feb9b6/9-stellungnahme-long-covid-data.pdf?download=1.</Citation></Reference><Reference><Citation>Finnigan LEM, Cassar MP, Koziel MJ, Pradines J, Lamlum H, Azer K, Kirby D, Montgomery H, Neubauer S, Valkovi&#x10d; L, Raman B. Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study. EClinicalMedicine. 2023;59:101946. doi: 10.1016/j.eclinm.2023.101946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101946</ArticleId><ArticleId IdType="pmc">PMC10102537</ArticleId><ArticleId IdType="pubmed">37223439</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrichson B, Kloka JA, Neef V, Mutlak H, Old O, Zacharowski K, Piekarski F. Extracorporeal membrane oxygenation in coronavirus disease 2019: A nationwide cohort analysis of 4279 runs from Germany. Eur J Anaesthesiol. 2022;39(5):445&#x2013;451. doi: 10.1097/EJA.0000000000001670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000001670</ArticleId><ArticleId IdType="pubmed">35180152</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopi S, und E.J. Soltas. The Impacts of Covid-19 Illnesses on Workers. NBER Working Paper No. 30435. 2022.&#xa0;http://www.nber.org/papers/w30435.</Citation></Reference><Reference><Citation>Hammond J, Leister-Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med. 2022;386(15):1397&#x2013;1408. doi: 10.1056/NEJMoa2118542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2118542</ArticleId><ArticleId IdType="pmc">PMC8908851</ArticleId><ArticleId IdType="pubmed">35172054</ArticleId></ArticleIdList></Reference><Reference><Citation>Himmler S, Mueller M, Sherif B, Ostwald D. A case study applying a novel approach to estimate the social impact of a medical innovation-the use of secukinumab for psoriatic arthritis in Germany. Expert Rev Pharmacoecon Outcomes Res. 2020;20(4):369&#x2013;378. doi: 10.1080/14737167.2019.1644169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737167.2019.1644169</ArticleId><ArticleId IdType="pubmed">31322444</ArticleId></ArticleIdList></Reference><Reference><Citation>Institut f&#xfc;r Arbeitsmarkt- und Berufsforschung (2020), IAB-Forschungsbericht. 16|2020 Entwicklung von Erwerbst&#xe4;tigkeit, Arbeitszeit und Arbeitsvolumen nach Geschlecht. https://doku.iab.de/forschungsbericht/2020/fb1620.pdf.</Citation></Reference><Reference><Citation>IKK S&#xfc;dwest (2021), Long Covid: Versicherte in der Region gefragt. 8. Oktober 2021. https://www.krankenkassen-direkt.de/news/mitteilung/IKK-Suedwest-Long-Covid-Versicherte-in-der-Region-gefragt-Mehrheit-der-Befragten-hat-Langzeitfolgen-3081400.html.</Citation></Reference><Reference><Citation>Koumpias AM, Schwartzman D, Fleming O. Long-haul COVID: healthcare utilization and medical expenditures 6 months post-diagnosis. BMC Health Serv Res. 2022;22:1010. doi: 10.1186/s12913-022-08387-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-022-08387-3</ArticleId><ArticleId IdType="pmc">PMC9358916</ArticleId><ArticleId IdType="pubmed">35941617</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorusso R, De Piero ME, Mariani S, Di Mauro M, Folliguet T, Taccone FS, Camporota L, Swol J, Wiedemann D, Belliato M, Broman LM, Vuylsteke A, Kassif Y, Scandroglio AM, Fanelli V, Gaudard P, Ledot S, Barker J, Boeken U, Maier S, Kersten A, Meyns B, Pozzi M, Pedersen FM, Schellongowski P, Kirali K, Barrett N, Riera J, Mueller T, Belohlavek J; EuroECMO-COVID Study Group. In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study. Lancet Respir Med. 2023;11(2):151&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671669</ArticleId><ArticleId IdType="pubmed">36402148</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinsey &amp; Company. Assessing the lingering impact of COVID-19 on the nursing workforce. May 11, 2022. https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/assessing-the-lingering-impact-of-covid-19-on-the-nursing-workforce.</Citation></Reference><Reference><Citation>McKinsey &amp; Company. One billion days lost: How COVID-19 is hurting the US workforce. January 9, 2023. https://www.mckinsey.com/industries/healthcare/our-insights/one-billion-days-lost-how-covid-19-is-hurting-the-us-workforce.</Citation></Reference><Reference><Citation>Mitteldeutscher Rundfunk (2022), Was kosten Corona-Patienten? Stand: 25. Januar 2022. https://www.mdr.de/nachrichten/deutschland/panorama/corona-behandlung-kosten-100.html#:~:text=Auch%20Patienten%2C%20die%20nach%20einer,Euro%2C%20so%20die%20AOK%20PLUS.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP) (2022), COVID-19 rapid guideline: managing the longterm effects of COVID-19. Version 1.14 published on 01.03.2022. https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742.</Citation></Reference><Reference><Citation>Nicholson S, Pauly MV, Polsky D, et al. Measuring the effects of work loss on productivity with team production. Health Econ. 2006;15(2):111&#x2013;123. doi: 10.1002/hec.1052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hec.1052</ArticleId><ArticleId IdType="pubmed">16200550</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for Budget Responsibility: Economic and fiscal outlook. Presented to Parliament by the Exchequer Secretary to the Treasury by Command of Her Majesty. March 2022. https://obr.uk//docs/dlm_uploads/CCS0222366764-001_OBR-EFO-March-2022_Web-Accessible-2.pdf.</Citation></Reference><Reference><Citation>Office for National Statistics. Coronavirus (COVID-19) latest insights: Infections. 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/infections#long-covid.</Citation></Reference><Reference><Citation>Office for National Statistics (ONS), released 23 February 2023, ONS website, statistical bulletin, New-onset, self-reported long COVID after coronavirus (COVID-19) reinfection in the UK: 23 February 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/newonsetselfreportedlongcovidaftercoronaviruscovid19reinfectionintheuk/23february2023.</Citation></Reference><Reference><Citation>PHOSP-COVID Collaborative Group Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022;10(8):761&#x2013;775. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuschke, D. und D. Houston (2022), The impact of Long COVID on the UK workforce. Applied Economics Letters, S. 1&#x2013;5.</Citation></Reference><Reference><Citation>Robert Koch-Institut (2022), Gesundheitliche Langzeitfolgen. Stand: 19.4.2022. https://www.rki.de/SharedDocs/FAQ/NCOV2019/FAQ_Liste_Gesundheitliche_Langzeitfolgen.html.</Citation></Reference><Reference><Citation>Rocks, S., G. Boccarini, A. Charlesworth, et al. (2021), Health and social care funding projections 2021. The Health Foundation; 2021 (10.37829/HF-2021-RC18).</Citation></Reference><Reference><Citation>Renaud-Charest O, Lui LM, Eskander S, et al. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. J Psychiatr Res. 2021;144:129&#x2013;137. doi: 10.1016/j.jpsychires.2021.09.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2021.09.054</ArticleId><ArticleId IdType="pmc">PMC8482840</ArticleId><ArticleId IdType="pubmed">34619491</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaffer L. Lots of long COVID treatment leads, but few are proven. Proc Natl Acad Sci USA. 2022;119(36):e2213524119. doi: 10.1073/pnas.2213524119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2213524119</ArticleId><ArticleId IdType="pmc">PMC9456722</ArticleId><ArticleId IdType="pubmed">36048910</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiliopoulos L, S&#xf8;rensen A.I, Bager&#xa0;P et al. Post-acute symptoms four months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study. medRxiv 2022.10.12.22280990. 2022.&#xa0;10.1101/2022.10.12.22280990.</Citation></Reference><Reference><Citation>Science (2022), Bad news for Paxlovid? Coronavirus can find multiple ways to evade COVID-19 drug. 29 June 2022. https://www.science.org/content/article/bad-news-paxlovid-coronavirus-can-find-multiple-ways-evade-covid-19-drug.</Citation></Reference><Reference><Citation>Skoda EM, Spura A, De Bock F, et al. Ver&#xe4;nderung der psychischen Belastung in der COVID-19-Pandemie in Deutschland: &#xc4;ngste, individuelles Verhalten und die Relevanz von Information sowie Vertrauen in Beh&#xf6;rden. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz. 2021;64(3):322&#x2013;33. doi: 10.1007/s00103-021-03278-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00103-021-03278-0</ArticleId><ArticleId IdType="pmc">PMC7821178</ArticleId><ArticleId IdType="pubmed">33481055</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistisches Bundesamt (2022), Erwerbst&#xe4;tigenquoten 1991 bis 2021. Stand 31. M&#xe4;rz 2022. https://www.destatis.de/DE/Themen/Arbeit/Arbeitsmarkt/Erwerbstaetigkeit/Tabellen/erwerbstaetigenquoten-gebietsstand-geschlecht-altergruppe-mikrozensus.html.</Citation></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagesschau (2022), US-Regierung verdoppelt Paxlovid-Order. Stand: 04.01.2022. https://www.tagesschau.de/ausland/amerika/usa-paxlovid-bestellung-verdoppelt-101.html.</Citation></Reference><Reference><Citation>Thomas, C., C. Jung, P. Patel, H. Quilter-Pinner und R. Statham (2022), Health and prosperity: Introducing the Commission on Health and Prosperity, IPPR. http://www.ippr.org/research/publications/health-and-prosperity.</Citation></Reference><Reference><Citation>Walter N, Rupp M, Lang S, Leinberger B, Alt V, Hinterberger T, Loew T. A Comprehensive Report of German Nationwide Inpatient Data on the Post-COVID-19 Syndrome Including Annual Direct Healthcare Costs. Viruses. 2022;14(12):2600. doi: 10.3390/v14122600.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122600</ArticleId><ArticleId IdType="pmc">PMC9781151</ArticleId><ArticleId IdType="pubmed">36560604</ArticleId></ArticleIdList></Reference><Reference><Citation>Welt (2022), Paxlovid: Das Corona-Medikament wird kaum verschrieben &#x2013; Woran liegt das? Stand: 29.06.2022. https://www.welt.de/gesundheit/plus239513215/Paxlovid-Das-Corona-Medikament-wird-kaum-verschrieben-Woran-liegt-das.html.</Citation></Reference><Reference><Citation>Wikipedia contributors. (2022, October 24). Marginal product of labor. In Wikipedia, The Free Encyclopedia. Retrieved 15:31, April 28, 2023, from https://en.wikipedia.org/w/index.php?title=Marginal_product_of_labor&amp;oldid=1117891289.</Citation></Reference><Reference><Citation>Wikipedia contributors. (2023, March 29). Labour economics. In Wikipedia, The Free Encyclopedia. Retrieved 15:49, April 28, 2023, from https://en.wikipedia.org/w/index.php?title=Labour_economics&amp;oldid=1147259836.</Citation></Reference><Reference><Citation>Wikipedia contributors. (2023, February 24). Gross value added. In&#xa0;Wikipedia, The Free Encyclopedia. Retrieved 15:56, May 1, 2023, from&#xa0;https://en.wikipedia.org/w/index.php?title=Gross_value_added&amp;oldid=1141227154.</Citation></Reference><Reference><Citation>Wissenschaftliches Institut der AOK. Krankschreibungen aufgrund von Long-COVID oder Post-COVID: Wenige Betroffene, aber lange krankheitsbedingte Ausfallzeiten. September 14, 2022. https://www.wido.de/news-presse/pressemitteilungen/2022/krankschreibungen-aufgrund-von-long-covid-oder-post-covid/.</Citation></Reference><Reference><Citation>Wikipedia &#x2013; Die freie Enzyklop&#xe4;die. Seite &#x201e;Gender-Pay-Gap&#x201c;. Bearbeitungsstand: 7. April 2023, 09:48 UTC. URL: https://de.wikipedia.org/w/index.php?title=Gender-Pay-Gap&amp;oldid=232565529.</Citation></Reference><Reference><Citation>Xie Y, Choi T, Al-Aly Z. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition. JAMA Intern Med. 2023;23:e230743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037200</ArticleId><ArticleId IdType="pubmed">36951829</ArticleId></ArticleIdList></Reference><Reference><Citation>Yahoo Finance (2022), Long COVID is a new disability affecting millions of workers&#x2014;and a &#x2018;moment of essential innovation&#x2019; for employers, one lawyer contends.https://finance.yahoo.com/news/long-covid-disability-affecting-millions-090000386.html.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>